I am thinking the role of doxorubicin's pathways in cancers such as leukemia and lymphoma:

* topoisomerase inhibitor and inhibit DNA activity
* intercalant - intercalant DNA bases and inhibit DNA activity

I am interested in which of these mechanisms are most relevant in leukemia and lymphoma. 

How does doxorubicin work in leukemia and lymphoma?